Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
2,5mg and 5mg Zolmitriptan Rapidfilm® uses oral dissolving film strip technology without need of water. More
Device and Process for Economical, Semi-Continuous Biodegradable Microsphere Production More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2011 - 7 pages - $3,835
Jun 2008 - $2,500
Dec 2007 - 56 pages - $495
May 2011 - 5 pages - $500
Jan 2010 - $75
Dec 2010 - 93 pages - $500
Feb 2011 - 41 pages - $125
Apr 2011 - 106 pages - $3,500
Nov 2007 - $2,500
Sep 2011 - 43 pages - $99
Your selection
Browse By
- Industry sector
- Advertising
- Business services
- Clinical research
- Communications
- Consultancy
- Distribution
- Event management
- Finance
- Information technology
- Laboratory equipment
- Legal
- Manufacturing
- Market research
- Marketing
- Materials
- Medical education
- Packaging
- Patents
- Pharmacovigilance
- Product development
- Public relations
- Publishers
- Recruitment
- Regulatory affairs
- Research
- Training
- Therapeutic target
- Amenorrahea
- Androgen deficiency
- Endocrine system
- Estrogen replacement
- Growth disorders
- Hormonal disorder (other)
- Hormone replacement therapy
- Hurler's syndrome
- Hypogonadism
- Hypothalamic
- Menopause
- Pancreatic exocrine insufficiency
- Sex hormone (other)
- Testosterone replacement
- Thyroid disorders
- Turner's syndrome
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us